MAPT and tauopathy: We found that this treatment: (1) improved cognitive function and broadly reduced neuroinflammation in both models; (2) reduced tau pathology and glial cell activation while conferring neuroprotection; (3) reversed transcriptome changes common to brain aging and tauopathy; and (4) exerted favorable systemic effects.